NCT00501722 - Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions

AscitesLiver Cirrhosis

Interventions

DRUG

satavaptan (SR121463B)

Trial Locations (13)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Cove

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Barcelona